Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Suicide risk and efficacy of antidepressant drugs--reply.

Gibbons RD, Brown CH, Hur K, Davis JM, Mann JJ.

JAMA Psychiatry. 2013 Jan;70(1):123-5. doi: 10.1001/jamapsychiatry.2013.758. No abstract available.

PMID:
23303376
2.

Suicide risk and efficacy of antidepressant drugs.

Carroll BJ.

JAMA Psychiatry. 2013 Jan;70(1):123-4. doi: 10.1001/jamapsychiatry.2013.756. No abstract available.

PMID:
23303338
3.

Inappropriate data and measures lead to questionable conclusions--reply.

Gibbons RD, Brown CH, Hur K, Davis JM, Mann JJ.

JAMA Psychiatry. 2013 Jan;70(1):122-3. doi: 10.1001/jamapsychiatry.2013.749. No abstract available.

PMID:
23303298
4.

Inappropriate data and measures lead to questionable conclusions.

Spielmans GI, Jureidini J, Healy D, Purssey R.

JAMA Psychiatry. 2013 Jan;70(1):121-2. doi: 10.1001/jamapsychiatry.2013.747. No abstract available.

PMID:
23303283
5.

Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine.

Gibbons RD, Brown CH, Hur K, Davis J, Mann JJ.

Arch Gen Psychiatry. 2012 Jun;69(6):580-7. doi: 10.1001/archgenpsychiatry.2011.2048. Erratum in: Arch Gen Psychiatry.2013 Aug;70(8):881.

6.

Venlafaxine versus fluoxetine.

Paton C.

J Clin Psychiatry. 1999 Oct;60(10):708. No abstract available.

PMID:
10549691
7.

Venlafaxine versus SSRI therapy for major depression. Results of comparative efficacy trials.

Bakish D.

Postgrad Med. 1999 Nov;106(6 Suppl):24-30. doi: 10.3810/pgm.11.1999.suppl1.4.

PMID:
19667501
8.

Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.

Davidson JR, Meoni P, Haudiquet V, Cantillon M, Hackett D.

Depress Anxiety. 2002;16(1):4-13.

PMID:
12203668
9.

Antidepressant use during pregnancy. FPIN’s clinical inquiries.

Patel BN, Beste J, Blackwell JC.

Am Fam Physician. 2011 May 15;83(10):1211-5. No abstract available.

10.

Venlafaxine-induced excessive yawning.

Chen CH, Lu ML.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Feb 1;33(1):156-7. doi: 10.1016/j.pnpbp.2008.10.014. Epub 2008 Oct 31. No abstract available.

PMID:
19000733
11.

A case of high-dose venlafaxine-related psychosis.

Dennison EA, Raidoo BM, Cruz R, Raidoo D.

J Clin Psychopharmacol. 2013 Feb;33(1):134-6. doi: 10.1097/01.jcp.0000426184.68487.d3. No abstract available.

PMID:
23288238
12.

Agomelatine: new drug. Adverse effects and no proven efficacy.

[No authors listed]

Prescrire Int. 2009 Dec;18(104):241-5.

PMID:
20020562
13.

Medication-associated somnambulism.

Lange CL.

J Am Acad Child Adolesc Psychiatry. 2005 Mar;44(3):211-2. No abstract available.

PMID:
15725964
14.

Fluoxetine and suicidal ideation.

Ratan DA.

J Clin Psychopharmacol. 1997 Feb;17(1):61-2. No abstract available.

PMID:
9004066
15.

Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.

Lam RW, Lönn SL, Despiégel N.

Int Clin Psychopharmacol. 2010 Jul;25(4):199-203. doi: 10.1097/YIC.0b013e32833948d8.

PMID:
20357664
16.

Suicidality in pediatric patients treated with antidepressant drugs.

Hammad TA, Laughren T, Racoosin J.

Arch Gen Psychiatry. 2006 Mar;63(3):332-9.

PMID:
16520440
18.

SSRIs: are the accusations justified?

Möller HJ.

World J Biol Psychiatry. 2004 Oct;5(4):174-5. No abstract available.

PMID:
15543512
19.

Antidepressants and side effects.

Grounds D, Stocky A, Evans P, Scott C, McIntosh R, Morrison E, Derham H, Yeatman R, Farnbach P.

Aust N Z J Psychiatry. 1995 Mar;29(1):156-7. No abstract available.

PMID:
7625967
20.

Pharmacotherapy of major depressive disorder in adolescents.

Masi G, Liboni F, Brovedani P.

Expert Opin Pharmacother. 2010 Feb;11(3):375-86. doi: 10.1517/14656560903527226. Review.

PMID:
20102303

Supplemental Content

Support Center